Publications by authors named "David M Knight"

Claim this Profile
A
A peptide immunization approach to counteract a Staphylococcus aureus protease defense against host immunity.
Robert E Jordan, Jeffrey Fernandez, Randall J Brezski, Allison R Greenplate, David M Knight

Immunol Lett· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The HSP90 molecular chaperone cycle regulates cyclical transcriptional dynamics of the glucocorticoid receptor and its coregulatory molecules CBP/p300 during ultradian ligand treatment.
Becky L Conway-Campbell, Charlotte L George, John R Pooley, David M Knight, Michael R Norman

Mol Endocrinol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The origins, specificity, and potential biological relevance of human anti-IgG hinge autoantibodies.
Randall J Brezski, David M Knight, Robert E Jordan

ScientificWorldJournal· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential effect of glucocorticoid receptor antagonists on glucocorticoid receptor nuclear translocation and DNA binding.
Francesca Spiga, David M Knight, Susanne K Droste, Becky Conway-Campbell, Yvonne Kershaw

J Psychopharmacol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
De novo selection of high-affinity antibodies from synthetic fab libraries displayed on phage as pIX fusion proteins.
Lei Shi, John C Wheeler, Raymond W Sweet, Jin Lu, Jinquan Luo, David M Knight

J Mol Biol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and development of biopharmaceuticals: current issues.
William R Strohl, David M Knight

Curr Opin Biotechnol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-associated and microbial proteases compromise host IgG effector functions by a single cleavage proximal to the hinge.
Randall J Brezski, Omid Vafa, Diane Petrone, Susan H Tam, Gordon Powers, David M Knight

Proc Natl Acad Sci U S A· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockade of the V(1b) receptor reduces ACTH, but not corticosterone secretion induced by stress without affecting basal hypothalamic-pituitary-adrenal axis activity.
Francesca Spiga, Louise R Harrison, Susan Wood, David M Knight, Cliona P MacSweeney

J Endocrinol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human anti-IgG1 hinge autoantibodies reconstitute the effector functions of proteolytically inactivated IgGs.
Randall J Brezski, Jennifer L Luongo, Diane Petrone, Mary H Ryan, Degang Zhong, David M Knight

J Immunol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The anxiogenic drug FG-7142 increases serotonin metabolism in the rat medial prefrontal cortex.
Andrew K Evans, Jolane K Abrams, J Adriaan Bouwknecht, David M Knight, Anantha Shekhar

Pharmacol Biochem Behav· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A MUC1/IL-18 DNA vaccine induces anti-tumor immunity and increased survival in MUC1 transgenic mice.
Linda A Snyder, Theresa J Goletz, George R Gunn, Frank F Shi, Michael C Harris, David M Knight

Vaccine· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamic enhancement of the anti-platelet antibody fab abciximab by site-specific pegylation.
David M Knight, Robert E Jordan, Marian Kruszynski, Susan H Tam, Jill Giles-Komar

Platelets· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis